Genetic Engineering & Biotechnology NewsControllable "Swiss Army Knife" CAR T Cells Solve Key Efficacy and Safety IssuesGenetic Engineering & Biotechnology NewsChimeric antigen receptor (CAR)-expressing T cells represent a promising approach … Continue reading
Healthcare JournalSynthetic Biology Market To See Incredible Growth By 2022 …Healthcare JournalSynthetic biology is a combination of biology and biomedical engineering principles that favors designing and construction of novel biological parts & … Continue reading
European Pharmaceutical ReviewExperimental arthritis drug prevents stem cell transplant complicationEuropean Pharmaceutical ReviewAn investigational drug in clinical trials for rheumatoid arthritis prevents a common, life-threatening side effect of ste… Continue reading
Allergy Immunotherapy Market to exceed US$ 3.33 Bn by 2025, Says TMRGlobeNewswire (press release)Albany, NY, April 27, 2018 (GLOBE NEWSWIRE) –. The global allergy immunotherapy market was valued at US$ 1.37 Bn in 2016 and is projected to register a cu… Continue reading
Gene Therapy Analysis in Global & US Market – Leading Players are Spark Therapeutics, LLC, Advantagene Inc …Medgadget (blog)WiseGuyReports have announced the addition of a new report titled “Global & US Gene Therapy Market Forecast to 2020”. … Continue reading
Muscular Dystrophy News |
Gene Therapy MYO-101 Receives FDA’s Orphan Drug Status for LGMD2E Treatment
Muscular Dystrophy News The U.S. Food and Drug Administration (FDA) granted orphan drug status to MYO-101, a gene therapy being developed by Myonexus Therapeutics for the treatment of limb girdle muscular dystrophy type 2E (LGMD2E) . The FDA’s orphan drug designation is … |
Quartz |
After gene-editing, Crispr’s new frontier to detect diseases is closer to becoming a reality
Quartz The world is one step closer to using Crispr, a powerful gene-editing tool, to solve one of the hardest parts of being a doctor: figuring out what is wrong with a patient. While there are a range of diagnostic tools to help doctors with that very first … CRISPR/Cas9 Silences Gene Associated with High CholesterolDuke Today All you need to know for round 2 of the CRISPR patent fightSTAT CRISPR at Home: Health for the Whole FamilyGenetic Engineering & Biotechnology News Genetic Literacy Project –Futurity: Research News all 12 news articles » |